BioSpace News Archive

Business

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, January 31, 2018

Thermo Fisher Scientific announced that it will release its financial results for the 2017 fourth quarter and full year before the market opens on Wednesday, January 31, 2018, and will hold a conference call on the same day at 8:30 a.m. EDT.

January 5, 2018
·
1 min read
Business

Retrophin and Censa Pharmaceuticals Enter Into Strategic Collaboration to Advance CNSA-001 for the Treatment of Phenylketonuria (PKU)

Retrophin obtains exclusive option to purchase Censa post proof-of-concept study.

January 5, 2018
·
7 min read
Biotech Beach

ABS Release: Major Heart Treatment to Eliminate Thousands of Open Heart Surgeries

Advanced Bifurcation Systems is developing a new procedure that could potentially eliminate the need for open-heart surgery in thousands of patients every year.

January 5, 2018
·
4 min read
Genetown

CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares

The offering is expected to close on or about January 9, 2018, subject to customary closing conditions.

January 5, 2018
·
4 min read
Deals

Upsher-Smith’s Parent Company Completes Stake Transfer to Sumitomo Corporation in U.S. Generics Market

Upsher-Smith today reported that on January 3, 2018, its parent company, Sawai successfully completed the sale of a 20 percent stake in Sawai America, LLC to Sumitomo Corporation of Americas.

January 5, 2018
·
2 min read
Genetown

RXi Pharmaceuticals Announces Reverse Stock Split

The reverse stock split will become effective at 12:01 a.m. Eastern Time on January 8, 2018.

January 5, 2018
·
7 min read
Pharm Country

Tauriga Sciences Completes Purchase of its First Tranche of Crypto Currency Groestlcoin

The Company had previously disclosed, via press release on December 27, 2017, that it decided to diversify $25,000 of its Net Cash Position into Groestlcoin and Gain Exposure to the Crypto Currency Sector.

January 5, 2018
·
3 min read
Pharm Country

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Jan. 5, 2018

The stock options and restricted stock units were granted as inducements material to the new employees becoming employees of Aclaris in accordance with NASDAQ Listing Rule 5635(c)(4).

January 5, 2018
·
2 min read
APEIRON to Present at the Biotech Showcase Annual Conference on January 9, 2018

APEIRON today announced that it will present at Biotech Showcase 2018, to be held January 8-10 at the Hilton San Francisco Union Square during one of the most important weeks in healthcare investing.

January 5, 2018
·
1 min read
Business

Rigel Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Rigel Pharma today announced that on December 23, 2017 and January 2, 2018 the Compensation Committee of Rigel’s Board of Directors approved the grants of inducement stock options to purchase an aggregate of 200,000 shares of common stock to twelve new employees.

January 5, 2018
·
2 min read